Literature DB >> 10210987

The risks and benefits of cisapride in premature neonates, infants, and children.

A Lander1, A Desai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10210987      PMCID： PMC1717773          DOI： 10.1136/adc.79.6.469

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  29 in total

1.  Long-term use of cisapride (Prepulsid) in premature neonates.

Authors:  K Melis; G Janssens
Journal:  Acta Gastroenterol Belg       Date:  1990 Jul-Aug       Impact factor: 1.316

2.  Effect of cisapride on chronic idiopathic constipation in children.

Authors:  A Staiano; S Cucchiara; M R Andreotti; R Minella; G Manzi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers.

Authors:  T Hedner; J Hedner; A Gelin-Friberg; M L Huang; S Van de Poel; R Woestenborghs; A Van Peer; J Heykants
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  QT interval in children and infants receiving cisapride.

Authors:  A Levine; R Fogelman; L Sirota; Z Zangen; R Shamir; G Dinari
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

5.  Cisapride decreases prolonged episodes of reflux in infants.

Authors:  Y Vandenplas; C de Roy; L Sacre
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-01       Impact factor: 2.839

6.  Cisapride for gastro-oesophageal reflux and peptic oesophagitis.

Authors:  S Cucchiara; A Staiano; C Capozzi; C Di Lorenzo; A Boccieri; S Auricchio
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

7.  Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children.

Authors:  A Malfroot; Y Vandenplas; M Verlinden; A Piepsz; I Dab
Journal:  Pediatr Pulmonol       Date:  1987 Jul-Aug

8.  Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.

Authors:  C Di Lorenzo; S N Reddy; J Villanueva-Meyer; I Mena; S Martin; P E Hyman
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

9.  New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.

Authors:  A Malfroot; I Dab
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

10.  Effect of cisapride on gastroesophageal reflux in children with chronic bronchopulmonary disease: a double-blind cross-over pH-monitoring study.

Authors:  Z N Saye; P P Forget; F Geubelle
Journal:  Pediatr Pulmonol       Date:  1987 Jan-Feb
View more
  2 in total

1.  Should cisapride have been "blacklisted"?

Authors:  M Markiewicz; Y Vanden Plas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

Review 2.  Efficacy and tolerability of cisapride in children.

Authors:  Y Vandenplas; A Benatar; F Cools; A Arana; B Hegar; B Hauser
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.